Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Sees Large Increase in Short Interest

Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) was the recipient of a significant growth in short interest in January. As of January 15th, there was short interest totalling 283,300 shares, a growth of 113.3% from the December 31st total of 132,800 shares. Based on an average daily volume of 128,139,400 shares, the short-interest ratio is presently 0.0 days.

Therapeutic Solutions International Stock Performance

Shares of TSOI stock traded down $0.00 during trading hours on Wednesday, hitting $0.00. 3,282,685 shares of the company’s stock were exchanged, compared to its average volume of 43,973,766. Therapeutic Solutions International has a 52 week low of $0.00 and a 52 week high of $0.00.

About Therapeutic Solutions International

Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.